15 April 2024
One Health Group PLC
("One Health")
Two Major Contracts Renewed on
Significantly Longer Terms
One Health Group PLC (AQSE: OHGR), the
independent provider of free high quality NHS care for patients
referred for treatment in Orthopaedics, Spine, General Surgery and
Gynaecology, announces that two of the largest NHS commissioners
with which it works have renewed their contracts. It is expected
that these new agreements will run for five years rather than
twelve months, which has been the case previously, and will cover
approximately 4,000 new patients and 2,000 surgical procedures per
year.
The two contracts are with Lincolnshire
Integrated Care Board (ICB) and South Yorkshire ICB who also act as
One Health's lead commissioner for Derby and Derbyshire and West
Yorkshire ICB's. Under these agreements, One Health will continue
to provide free care to NHS patients over a longer term in
Doncaster, Barnsley, Rotherham, Sheffield, Wakefield, Kirklees,
Leeds, Bradford, Calderdale, Derby and Derbyshire and most of
Lincolnshire. One Health has worked with the majority of these NHS
commissioners for over 10 years.
Prior to these agreements being established, One
Health operated under multiple, individual 12-month Clinical
Commissioning Group contracts with each one being renewed every
April. Following the establishment of ICB's, and the abolition of
Clinical Commissioning Groups in July 2022, the annual contracts
continued, but incorporated wider regions that were previously
covered by individual CCG contracts.
Under the new contracts, rather than conducting
a 'mini tender' process across multiple regions every year, One
Health will provide updated policies and supporting documentation
as well as anticipated activity levels for the following year by
region. As pricing will continue to be set by the 'National NHS
Tariff' there is no requirement for any financial negotiations.
This means the amount of time and effort spent administering
renewals by both the NHS and One Health, will be significantly
reduced.
One Health will be publishing a trading update
for the group for the year to 31 March 2024 on Monday 29 April
2024.
Adam Binns - CEO of One Health Group said:
"These
longer-term commitments are a clear indication of the value we
deliver to the NHS' infrastructure and also demonstrate the vital
role we play in its supply chain. Most importantly, having this
certainty in place will allow us to focus even more closely on
activities that make a difference to the lives of patients as we
will have the confidence to consider new investments in facilities
and additional support services at a time when central government
public funding is under pressure."
ends
About One
Health Group
One Health engages over 100 NHS Consultants who
sub-specialise in the various surgeries offered by the Group,
through a growing network of community-based outreach clinics and
surgical operating locations. In the year to March 2023 One Health
serviced almost 12,000 new patients, through over 29,000
consultations and performed 5,790 surgical procedures. One Health
uses surgeons and anaesthetists that are mostly employed by the
NHS, on a consultancy basis. It currently works with over 100
professionals across seven hospitals and over 30 CQC registered
clinics.
One Health's activities are focused on areas where the
patient needs are under-supplied by the local NHS service as well
as locations where population density is relatively high, and the
level of private medical insurance is relatively low. One Health
has also sought to expand geographically from its head office in
Sheffield, South Yorkshire into neighbouring counties, which meet
the required criteria. Currently, the Group's activities are
focused in Yorkshire, Lincolnshire, Derbyshire, Nottinghamshire and
Leicestershire. Revenue in the year to 31 March 2023 was derived
from 60 Clinical Commissioning Groups in addition to contracts
directly with NHS hospitals to manage their internal waiting
lists.
One Health's business model has focused to date on
four main areas: being Spine, Orthopaedics, General Surgery and
Gynaecology. The split of inpatient procedures in the year to 31
March 2023 was as follows: Orthopaedics 44% Spine 27% General
Surgery 22% Gynaecology 7%.
Orthopaedics and Spine are particularly attractive
areas for One Health as the Directors believe that they benefit
from powerful growth drivers in terms of an ageing demographic,
physical inactivity and an increasing proportion of the population
being categorised as obese. Within orthopedics, the most common
surgeries performed by One Health are knee and hip
replacements.
*(https://www.onehealth.co.uk/investors)
The Directors of
One Health Group plc accept responsibility for the contents of this
announcement.
For more information, please
contact:
One Health Group
plc
via Square1
Consulting
Oberon Capital - AQSE
Corporate Adviser and
Broker
+44 203 179
5300
Nick Lovering
Mike Seabrook
Adam Pollock
Square1
Consulting
+44 207 929
5599
David
Bick
+44 7831 381201
